Board of trustees
Prof. Dr. med. Mathias Freund
- Chairman of the board of trustees
- Born in 1949
- 1994 to 2012: Director of the Clinic of Hematology and Oncology, University Medical Center Rostock
- 1994 to 2012: Director of the Clinic of Hematology and Oncology, University Medical Center Rostock
- 2013 to 2015: Executive Director of German Society for Hematology and Medical Oncology e.V. (DGHO)
- Chairman of the Cancer Society Mecklenburg-Western Pomerania and active in numerous other scientific societies in Germany, Europe and the USA
- Scientific work in the field of acute and chronic leukemia, lymphomas, cytokines, haemostaseology, bone marrow and blood stem cell transplantation, stem cell research and regenerative medicine
- Co-initiator of the Biomedical Research Center Rostock
Prof. Dr. med. Volker Diehl
- Member of the Board of Trustees
- Born in 1938
- Study of human medicine, specialist in internal medicine and haemato-oncology
- Transformation of umbilical cord blood B lymphocytes with Epstein-Barr virus (EBV) from Burkitt’s lymphoma cells
- First cultivation of Hodgkin-Sternberg cells in cell lines in vitro
- Foundation of the German Hodgkin Study Group (GHSG)
- 1983 to 2003: Professor of Internal Medicine at the University of Cologne
- Development of the BEACOPP regimen for the treatment of Hodgkin’s disease
- Founding director of the National Cancer Center in Heidelberg
- Winner of various awards
Prof. Dr. med. Carl F. Classen
- Member of the Board of Trustees
- Born in 1962
- Specialist in paediatrics with continuing education in paediatric hematology and oncology
- Senior physician at the University Children’s and Youth Hospital at the University Hospital Rostock
- Head of the Brain Tumor Vaccine Working Group
PD Dr. med. Inken Hilgendorf
- Member of the Board of Trustees
- Born in 1974
- Study of human medicine
- Specialist in internal medicine, hematology and oncology
- Section leader for stem cell transplantation at the University Hospital Jena
- Scientific work in the field of hematopoietic stem cell transplantation including immune reconstitution, pathophysiology and therapy of donor-versus-host disease (GVHD) and long-term follow-up
- Chairwoman of the AYA network of DGHO
